Anbio Biotechnology SEC EDGAR Filings (CIK 0001982708)

SEC EDGAR filings, ownership reports, and insider transactions for Anbio Biotechnology.

Symbol
NNNN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances (Office Of Life Sciences)
Business address
Friedrich Ebert Anlage 49, Frankfurt Am Main, Germany, 60308
State of incorporation
Cayman Islands
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Anbio Biotechnology has filed 29 SEC EDGAR filings since 27 Dec 2023

Latest Filings

Recent SEC filings for Anbio Biotechnology including 6-K, 20-F, 424B4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 30 Dec 2025 30 Dec 2025 001-42526
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 13 Nov 2025 12 Nov 2025 001-42526
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F ANNUAL REPORT 28 Apr 2025 31 Dec 2024 001-42526
6-K Open 6-K document View SEC filing for 6-K REPORT OF FOREIGN PRIVATE ISSUER 21 Feb 2025 21 Feb 2025 001-42526
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 19 Feb 2025 333-284106
EFFECT Open EFFECT document View SEC filing for EFFECT 18 Feb 2025 333-284106
CERT Open CERT document View SEC filing for CERT 18 Feb 2025 001-42526
CORRESP Open CORRESP document View SEC filing for CORRESP 14 Feb 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 14 Feb 2025
8-A12B Open 8-A12B document View SEC filing for 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 14 Feb 2025 001-42526
F-1/A Open F-1/A document View SEC filing for F-1/A REGISTRATION STATEMENT 10 Feb 2025 333-284106
F-1/A Open F-1/A document View SEC filing for F-1/A REGISTRATION STATEMENT 24 Jan 2025 333-284106
FWP Open FWP document View SEC filing for FWP FREE WRITING PROSPECTUS 22 Jan 2025 333-284106
F-1/A Open F-1/A document View SEC filing for F-1/A REGISTRATION STATEMENT 10 Jan 2025 333-284106
F-1 Open F-1 document View SEC filing for F-1 REGISTRATION STATEMENT 31 Dec 2024 333-284106
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 11 Dec 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 11 Dec 2024 377-07031
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 04 Dec 2024 377-07031
DRS/A Open DRS/A document View SEC filing for DRS/A 18 Nov 2024 377-07031
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 01 Jul 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 01 Jul 2024 377-07031
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 21 Jun 2024 377-07031
DRS/A Open DRS/A document View SEC filing for DRS/A 10 Jun 2024 377-07031
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 07 Jun 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 22 Mar 2024 377-07031
DRS/A Open DRS/A document View SEC filing for DRS/A 11 Mar 2024 377-07031
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 08 Mar 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 23 Jan 2024 377-07031
DRS Open DRS document View SEC filing for DRS 27 Dec 2023 377-07031

About this filer

Anbio Biotechnology files with the SEC under CIK 0001982708. This page aggregates EDGAR filings and related ownership activity.

Industry: In Vitro & In Vivo Diagnostic Substances.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages